These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11354235)

  • 1. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.
    Schweizer E; Rynn M; Mandos LA; Demartinis N; García-España F; Rickels K
    Int Clin Psychopharmacol; 2001 May; 16(3):137-43. PubMed ID: 11354235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?
    Trivedi MH; Rush AJ; Carmody TJ; Donahue RM; Bolden-Watson C; Houser TL; Metz A
    J Clin Psychiatry; 2001 Oct; 62(10):776-81. PubMed ID: 11816866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    Mehtonen OP; Søgaard J; Roponen P; Behnke K
    J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression.
    Möller HJ; Glaser K; Leverkus F; Göbel C
    Pharmacopsychiatry; 2000 Nov; 33(6):206-12. PubMed ID: 11147927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
    Fava M; Hoog SL; Judge RA; Kopp JB; Nilsson ME; Gonzales JS
    J Clin Psychopharmacol; 2002 Apr; 22(2):137-47. PubMed ID: 11910258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.
    Brecht S; Desaiah D; Marechal ES; Santini AM; Podhorna J; Guelfi JD
    J Clin Psychiatry; 2011 Aug; 72(8):1086-94. PubMed ID: 20868642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
    Steiner M; Allgulander C; Ravindran A; Kosar H; Burt T; Austin C
    Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
    Finkel SI; Richter EM; Clary CM
    Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.
    Liebowitz MR; Yeung PP; Entsuah R
    J Clin Psychiatry; 2007 Nov; 68(11):1663-72. PubMed ID: 18052559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
    Lépine JP; Goger J; Blashko C; Probst C; Moles MF; Kosolowski J; Scharfetter B; Lane RM
    Int Clin Psychopharmacol; 2000 Sep; 15(5):263-71. PubMed ID: 10993128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.